tyrosine and Benign Neoplasms, Brain

tyrosine has been researched along with Benign Neoplasms, Brain in 283 studies

Research

Studies (283)

TimeframeStudies, this research(%)All Research%
pre-19906 (2.12)18.7374
1990's13 (4.59)18.2507
2000's51 (18.02)29.6817
2010's158 (55.83)24.3611
2020's55 (19.43)2.80

Authors

AuthorsStudies
Baučić, M; Golubić, AT; Hodolič, M; Huić, D; Mišir Krpan, A; Mrak, G; Nemir, J; Žuvić, M1
Cho, MS; Jang, Y; Kang, SY; Kim, BS; Kim, HO; Moon, BS; Park, SJ; Yoon, HJ1
McBean, R; Perkins, E; Tatkovic, A; Wong, D1
Blume, C; Clusmann, H; Delev, D; Galldiks, N; Hakvoort, K; Hamou, HA; Heiland, DH; Kernbach, JM; Langen, KJ; Lohmann, P; Mottaghy, FM; Neuloh, G; Ort, J1
Bauer, EK; Felsberg, J; Fink, GR; Galldiks, N; Kocher, M; Langen, KJ; Lohmann, P; Rapp, M; Rosen, J; Stoffels, G; Werner, JM; Wollring, M1
Buolamwini, JK; Deokar, H; Pfeffer, LM; Raje, M; Sacher, JR; Sims, MM; Turkson, J; Wang, Y; Yang, C; Yue, P1
Kang, SY; Kim, BS; Moon, BS; Yoo, MY; Yoon, HJ1
Anderson, JB; Choi, J; Daniels, DJ; Day, CA; Decker, PA; Ge, J; Hamdan, FH; Hinchcliffe, EH; Johnsen, SA; Kaptzan, T; Lu, VM; Nesvick, CL; Peterson, T; Power, EA; Siada, R; Simons, R; Welby, JP; Zhang, L1
Bauer, EK; Ceccon, G; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Heinzel, A; Herrlinger, U; Kabbasch, C; Langen, KJ; Rapp, M; Rosen, J; Ruge, M; Sabel, M; Schäfer, N; Stoffels, G; Tscherpel, C; Werner, JM1
Blok, M; Harat, M; Makarewicz, K; Małkowski, B; Miechowicz, I; Wiatrowska, I1
Doma, A; Skoblar Vidmar, M; Smrdel, U; Studen, A; Zevnik, K1
Allard, B; Ben Salem, D; Bourbonne, V; Dissaux, B; Dissaux, G; Keromnes, N; Latreche, A; Lepeuve, A; Mazouz Fatmi, D; Ognard, J; Querellou, S; Schick, U1
Bauer, EK; Ceccon, GS; Fink, GR; Galldiks, N; Goldbrunner, R; Kabbasch, C; Langen, KJ; Lohmann, P; Stoffels, G; Tscherpel, C; Werner, JM; Wollring, MM1
Albert, NL; Bartenstein, P; Bartos, LM; Herms, J; Holzgreve, A; Kaiser, L; Li, Z; Niyazi, M; Quach, S; Ruf, VC; Suchorska, B; Tonn, JC; Unterrainer, LM; Unterrainer, M; Wenter, V1
Albert, NL; Bartenstein, P; Bartos, LM; Brendel, M; Dekorsy, FJ; Herms, J; Holzgreve, A; Kaiser, L; Kirchleitner, SV; Nelwan, DV; Niyazi, M; Quach, S; Riemenschneider, MJ; Ruf, VC; Rupprecht, R; Stöcklein, S; Thon, N; Tonn, JC; Unterrainer, M; V Baumgarten, L; Weidner, L; Weller, J; Wetzel, C1
Combs, S; Gempt, J; Schlürmann, T; Waschulzik, B; Weber, W; Wiestler, B; Yakushev, I1
Detsky, J; Poon, R; Singnurkar, A1
Bison, B; Buck, AK; Dierks, A; Eyrich, M; Frühwald, MC; Kertels, O; Kircher, M; Krauß, J; Lapa, C; Mihovilovic, MI; Monoranu, CM; Pham, M; Samnick, S; Schlegel, PG1
Al Shughri, A; Brunn, A; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Rosen, EK; Rueß, D; Ruge, MI; Stetter, I; Tscherpel, C; Werner, JM; Werr, L; Wollring, MM1
Fink, GR; Galldiks, N; Langen, KJ; Lohmann, P1
Joshi, RK; Kumar, A; Kumar, D; Kumar, P; Nagaraj, C; Thakur, R1
Adda, L; Back, M; Bailey, DL; Barnes, EH; Coffey, R; De Abreu Lourenco, R; Ebert, M; Fitt, G; Foroudi, F; Francis, RJ; Gan, HK; Hicks, RJ; Khasraw, M; Koh, ES; Lasocki, A; Lau, E; Lee, ST; Leonard, R; Moffat, BA; Moore, A; Nowak, AK; Roach, P; Rosenthal, M; Scott, AM; Senko, C; Thomas, PA; Verhaak, R; Walsh, KM1
Ceccon, G; Galldiks, N; Gutsche, R; Isensee, F; Kocher, M; Langen, KJ; Lohmann, P; Lowis, C; Régio Brambilla, C; Shah, NJ; Ziemons, K1
Borbély, K; Fedorcsák, I; Kenessey, I; Nagy, DG1
Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Radbruch, H; Tietze, A1
Galldiks, N; Langen, KJ; Lohmann, P; Mottaghy, FM1
Cheresiz, S; Dyrkheeva, N; Kononova, A; Kovaleva, K; Lavrik, O; Mamontova, E; Oleshko, O; Pokrovsky, A; Salakhutdinov, N; Yarovaya, O; Zakharenko, A; Zakharova, O1
Cai, Q; Du, L; Jiang, BH; Jiang, T; Li, H; Li, X; Lorenzi, PL; Lu, Z; Qian, X; Shi, Z; Tan, L; Xia, Y; Xu, D; You, Y; Zhang, C; Zhao, D; Zheng, Y1
Bohner, G; Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Siebert, E1
Andrée Larsen, V; Bashir, A; Broholm, H; Grunnet, K; Law, I; Mathilde Jacobsen, S; Mølby Henriksen, O; Møller, S; Skjøth-Rasmussen, J; Skovgaard Poulsen, H; Urup, T1
Antoch, G; Demircioglu, A; Forsting, M; Glas, M; Gratz, M; Griswold, M; Gulani, V; Haubold, J; Herrmann, K; Kannengiesser, S; Keyvani, K; Nensa, F; Nittka, M; Sure, U; Umutlu, L; Wrede, K1
Akhoundova, D; Andratschke, N; Bankel, L; Curioni-Fontecedro, A; Förster, R; Hiltbrunner, S; Hüllner, M; Kollias, S; Kraft, J; Lee, SY; Mader, C; Rushing, EJ; Schwanhäusser, B; Treyer, V1
Cabello, J; Eichinger, P; Gempt, J; Hock, A; Karimov, I; Keupp, J; Liesche-Starnecker, F; Metz, M; Meyer, B; Molina-Romero, M; Preibisch, C; Pyka, T; Schön, S; Weber, W; Wiestler, B; Yakushev, I; Zimmer, C1
Filss, CP; Fink, GR; Galldiks, N; Goldbrunner, R; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Rapp, M; Sabel, M; Schmitz, AK; Shah, NJ; Stegmayr, C; Stoffels, G; Werner, JM1
Bauer, EK; Blau, T; Ceccon, G; Felsberg, J; Filss, CP; Fink, GR; Galldiks, N; Langen, KJ; Lohmann, P; Neumaier, B; Rapp, M; Reifenberger, G; Rosen, J; Sabel, M; Shah, NJ; Stoffels, G; Tscherpel, C; Werner, JM1
Bernstock, JD; Bhat, KP; Chagoya, G; Chiocca, EA; Elsayed, G; Estevez-Ordonez, D; Flanary, VL; Hackney, JR; Ilyas, A; Kim, SH; Kornblum, HI; Mohyeldin, A; Mooney, J; Nakano, I; Sadahiro, H; Yamaguchi, S; Yamashita, D; Zamboni, N1
Coenen, HH; Ermert, J; Filß, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Stegmayr, C; Stoffels, G; Willuweit, A1
Esposito, G; Fischer, DR; Fuenfgeld, B; Huellner, MW; Kaufmann, PA; Mächler, P; Rushing, EJ; Stolzmann, P1
Ben Salem, D; Bourhis, D; Dissaux, B; Dissaux, G; Gujral, DM; Kabbaj, OE; Pradier, O; Querellou, S; Salaün, PY; Schick, U; Seizeur, R1
Nabavizadeh, SA; Nasrallah, IM; Pryma, DA1
Filss, CP; Galldiks, N; Langen, KJ; Lohmann, P; Stegmayr, C1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Abdulla, DSY; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Hüllner, M; Kocher, M; Kreuzberg, N; Landsberg, J; Langen, KJ; Lohmann, P; Marnitz, S; Mauch, C; Ruge, MI; Scheffler, M; Schlaak, M; Schweinsberg, V; Stoffels, G; Tonn, JC; Trommer, M; Weller, M; Werner, JM; Wolf, J; Wolpert, F1
Caparrotti, F; Conen, K; Hottinger, AF; Hundsberger, T; Ochsenbein, A; Remonda, L; Roelcke, U; Roth, P; Tabatabai, G; von Moos, R; Weller, J; Weller, M; Wirsching, HG1
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Forbrig, R; Herms, J; Niyazi, M; Ruf, V; Rupprecht, R; Tonn, JC; Unterrainer, M; Vettermann, FJ1
Filipski, K; Filss, CP; Galldiks, N; Hattingen, E; Hmeidan, SA; Keil, F; Langen, KJ; Lohmann, P; Maurer, GD; Mottaghy, FM; Polomac, N; Shah, NJ; Steidl, E; Steinbach, JP1
Antoch, G; Bundschuh, RA; Colletti, PM; Forsting, M; Glas, M; Herrlinger, U; Herrmann, K; Kebir, S; Keyvani, K; Kleinschnitz, C; Lazaridis, L; Milia, A; Pierscianek, D; Rauschenbach, L; Rubello, D; Schäfer, N; Scheffler, B; Schmidt, T; Stuschke, M; Sure, U; Umutlu, L; Weber, M1
Brenner, W; Driever, PH; Grosse, F; Koch, A; Plotkin, M; Steffen, I; Thomale, UW; Wedel, F1
Brambilla, CR; Caldeira, L; Galldiks, N; Herzog, H; Jon Shah, N; Kops, ER; Langen, KJ; Lerche, CW; Lohmann, P; Radomski, T; Scheins, J; Tellmann, L1
Bourhis, D; Dissaux, B; Dissaux, G; Querellou, S; Schick, U1
Bello-Alvarez, C; Camacho-Arroyo, I; González-Arenas, A; Moral-Morales, AD1
Borgwardt, L; Broholm, H; Forman, JL; Henriksen, OM; Højgaard, L; Law, I; Lundemann, M; Marner, L; Mathiasen, R; Nysom, K; Sehested, A; Skjøth-Rasmussen, J; Thomsen, C; Wehner, PS; Østrup, O1
Blauensteiner, K; Calabek-Wohinz, B; Freydl, E; Hainz, K; Heinz, G; Marhold, F; Minear, G; Oberndorfer, S; Tesar-Pelz, M; Tinchon, A1
Bauer, EK; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Gielen, GH; Herrlinger, U; Kabbasch, C; Langen, KJ; Lohmann, P; Marnitz, S; Schäfer, N; Schaub, C; Stoffels, G; Tscherpel, C; Weller, J; Werner, JM1
Byun, BH; Chi, DY; Choi, CW; Kil, HS; Kim, BI; Lee, KC; Lim, I; Lim, SM; Moon, H; Park, C; Rhee, CH; Woo, SK; Youn, SM1
Black, D; Kaneko, S; Schipmann, S; Sporns, P; Stummer, W; Suero Molina, E1
Berkmann, S; Christ-Crain, M; Juengling, F; Mariani, L; Mueller, B; Nitzsche, E; Roethlisberger, M1
Filss, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Stegmayr, C; Stoffels, G; Willuweit, A1
Fouquet, JP; Lebel, R; Lepage, M; Richard, MA1
Langen, KJ; Loução, R; Oros-Peusquens, AM; Shah, NJ; Zimmermann, M1
Back, M; Bailey, D; Brazier, D; Chan, D; Jaymanne, DT; Kaushal, S; Schembri, G; Wheeler, H1
Albert, NL; Bartenstein, P; Biczok, A; Drexler, M; Giese, A; Schüller, U; Suchorska, B; Tonn, JC; Unterrainer, M; Weller, M1
Bumes, E; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; Riemenschneider, MJ1
Eickhoff, SB; Fink, GR; Galldiks, N; Guedj, E; Langen, KJ; Lohmann, P; Shah, NJ; Stegmayr, C; Stoffels, G; Van Der Gucht, A; Verger, A1
Giovanella, L; Muoio, B; Treglia, G1
Atwa, ST; Eltaoudy, MH; Omar, WM; Shama, SA; Siddiq, IS1
Choi, CH; da Silva, NA; Fairney, J; Galldiks, N; Golay, X; Jon Shah, N; Langen, KJ; Lohmann, P; Magill, AW; Oros Peusquens, AM; Stirnberg, R; Stoffels, G1
Blau, T; Ceccon, G; Fink, GR; Galldiks, N; Glas, M; Herrmann, K; Kebir, S; Langen, KJ; Lazaridis, L; Lohmann, P; Rapp, M; Stoffels, G; Weber, M1
Bashir, A; Brennum, J; Broholm, H; Law, I1
Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J1
Buck, AK; Ernestus, RI; Hänscheid, H; Kertels, O; Kessler, AF; Kleinlein, I; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S1
Gielen, GH; Giordano, FA; Glas, M; Herrlinger, U; Kebir, S; Lazaridis, L; Rauschenbach, L; Schäfer, N; Scheffler, B; Tzaridis, T1
Bartek, J; Daxberg, EL; Förander, P; Gempt, J; Jakola, AS; Laesser, M; Liljegren, A; Näslund, O; Smits, A1
Gempt, J; Hiob, D; Preibisch, C; Pyka, T; Schlegel, J; Straube, C; Wiestler, B; Zimmer, C1
Amunts, K; Galldiks, N; Geisler, S; Langen, KJ; Lohmann, P; Mohlberg, H; Oros-Peusquens, AM; Piroth, MD; Sellhaus, B; Shah, NJ; Weis, J1
Allinson, K; Bielik, R; Booth, T; Brindle, KM; Jones, J; Lewis, DY; Lyons, SK; Mair, R; Soloviev, D; Wright, A1
Bauer, EK; Ceccon, G; Fink, GR; Galldiks, N; Kocher, M; Langen, KJ; Lohmann, P; Neumaier, B; Ruge, MI; Shah, NJ; Stoffels, G; Viswanathan, S1
Albert, NL; Bartenstein, P; Diekmann, C; Dorostkar, M; Kümpfel, T; Tonn, JC; Unterrainer, M; Vettermann, FJ1
Bock, M; Bott, S; Grosu, AL; Mader, I; Meyer, PT; Mix, M; Nestle, U; Nieder, C; Oehlke, O; Popp, I; Schimek-Jasch, T; Urbach, H; Weber, WA; Yuh, WTC1
Buchmann, N; Gempt, J; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Ryang, YM1
Abdollahi, A; Afshar-Oromieh, A; Debus, C; Debus, J; Floca, R; Haberkorn, U; Ingrisch, M; Knoll, M1
Cook, R; Ibbett, I; Parkinson, J; Schembri, G1
Bauer, EK; Ceccon, G; Fink, GR; Galldiks, N; Langen, KJ; Lipke, K; Lohmann, P; Neumaier, B; Shah, NJ; Stavrinou, P; Werner, JM1
Belanger, AP; Dubey, S; George, E; Horky, L; Huang, RY; Kesari, S; Kijewski, MF; Park, MA; Reardon, DA; Wen, PY1
Albert, NL; Berding, G; Felsberg, J; Forbrig, R; Galldiks, N; Hasselblatt, M; la Fougère, C; Reifenberger, G; Schittenhelm, J; Schüller, U; Vettermann, FJ; Weis, J1
Chen, TC; Markland, FS; Minea, RO; Swenson, S; Thein, TZ; Tuan, CD1
Engelholm, S; Engelholm, SA; Grunnet, K; Law, I; Lundemann, MJ; Muhic, A; Munck Af Rosenschold, P; Roed, H; Skovgaard Poulsen, H1
Abdulla, DSY; Brandes, V; Büttner, R; Drzezga, A; Fischer, R; Galldiks, N; Grau, S; Kobe, C; Kunze, S; Merkelbach-Bruse, S; Michels, S; Nogova, L; Persigehl, T; Riedel, R; Ruge, M; Scheffler, M; Wolf, J1
Langen, KJ; Lohmann, P; Stegmayr, C; Willuweit, A1
Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V1
Buchmann, N; Gempt, J1
Benitez, JA; Boyer, A; Cavenee, WK; Chen, CC; DeGroot, J; Fenton, TR; Furnari, FB; Gahman, TC; Galatro, T; Koga, T; Kolodner, RD; Li, J; Lindahl, E; Ma, J; Miki, S; Nagahashi Marie, SK; Orellana, L; Ponte de Albuquerque, C; Reed, R; Shiau, AK; Sulman, EP; Varki, NM; Zanca, C; Zhou, H1
Duan, H; Fang, X; Kong, W; Qiu, J; Yu, Z1
Alberts, E; Angelikopoulos, P; Combs, SE; Diehl, C; Hadjidoukas, P; Koumoutsakos, P; Lipkova, J; Lowengrub, J; Menze, B; Preibisch, C; Pyka, T; Van Leemput, K; Wiestler, B; Wu, S1
Brändlein, S; Buck, AK; Ernestus, RI; Kertels, O; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S; Stolzenburg, A1
Galldiks, N; Langen, KJ; Lindemeyer, J; Lohmann, P; Neumaier, B; Shah, NJ; Shymanskaya, A; Stoffels, G; Worthoff, WA1
Albert, NL; Bartenstein, P; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Kreth, FW; Langen, KJ; Lohmann, P; Rapp, M; Stoffels, G; Suchorska, B; Tonn, JC; Unterrainer, M; Vettermann, F1
Boellaard, R; De Witt Hamer, PC; Hoekstra, OS; Koopman, T; Lammertsma, AA; Pouwels, PJ; Verburg, N; Wesseling, P; Yaqub, M1
Bolcaen, J; Boterberg, T; De Meulenaere, V; De Vos, F; Deblaere, K; Descamps, B; Donche, S; Goethals, I; Kalala, JP; Kersemans, K; Van den Broecke, C; Vanhove, C; Verhoeven, J1
Alexiou, GA; Fotopoulos, AD; Jabbour, P; Katsanos, AH; Kyritsis, AP; Sioka, C1
Koch, R; Müther, M; Schwindt, W; Sporns, P; Stummer, W; Weckesser, M1
Brumberg, J; Ernestus, RI; Kertels, O; Kessler, AF; Kircher, M; Lapa, C; Linsenmann, T; Löhr, M; Meyer, PT; Mihovilovic, MI; Monoranu, CM; Samnick, S; Tran-Gia, J1
Kamson, DO1
Albert, NL; Bartenstein, P; Belka, C; Corradini, S; Fleischmann, DF; Förster, S; la Fougère, C; Niyazi, M; Rottler, M; Schwaiger, M; Siepmann, T; Unterrainer, M1
Brunn, A; Fink, GR; Galldiks, N; Langen, KJ1
Pichler, R1
Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D1
Galldiks, N; Langen, KJ1
Langen, KJ1
Coenen, HH; Eble, MJ; Geisler, S; Langen, KJ; Piroth, MD; Prasath, J; Sellhaus, B; Shah, NJ; Stoffels, G; van Osterhout, A; Willuweit, A1
Blaum, M; Galldiks, N; Heinzel, A; Langen, KJ; Mottaghy, FM; Müller, D; Verburg, FA1
Fougère, Cl; Hutterer, M; Jacobs, AH; Nowosielski, M; Putzer, D; Stockhammer, G; Virgolini, IJ1
Burger, U; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Habermehl, D; Hoffmann, C; Rief, H; Rieken, S; Welzel, T1
De Souza, PC; Ehrenshaft, M; Gomez-Mejiba, SE; Henry, L; Lupu, F; Mason, RP; Ramirez, DC; Saunders, D; Silasi-Mansat, R; Smith, N; Towner, RA1
Coenen, HH; Eble, MJ; Galldiks, N; Langen, KJ; Liebenstund, S; Piroth, MD; Shah, NJ; Stoffels, G1
Kung, HF; Lieberman, BP; Ploessl, K; Wang, L1
Kawada, T1
Floeth, FW; Galldiks, N; Langen, KJ; Rapp, M; Reifenberger, G1
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Langen, KJ; Neuner, I; Rota Kops, E; Shah, NJ; Stoffels, G; Tellmann, L; Zhang, K1
Flentje, M; Polat, B; Reiners, C; Samnick, S; Sweeney, R; Verburg, FA1
Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S1
Bartenstein, P; Drexler, M; Eigenbrod, S; Jansen, NL; Kreth, FW; la Fougère, C; Niyazi, M; Schmid-Tannwald, C; Schnell, O; Suchorska, B; Thon, N; Tonn, JC; Wenter, V; Zwergal, A1
Berberat, J; Boxheimer, L; Bruehlmeier, M; Nitzsche, EU; Rahm, V; Remonda, L; Roelcke, U1
Chen, JH; Huang, SS; Lin, C; Lu, DY; Tsai, CF; Yeh, WL1
Förschler, A; Förster, S; Gempt, J; Grams, AE; Meyer, B; Ringel, F; Ryang, YM; Schlegel, J; Soehngen, E; Zimmer, C1
Bloch, J; Dunet, V; Lhermitte, B; Maeder, P; Meuli, R; Nicod-Lalonde, M; Pollo, C; Prior, JO; Stupp, R1
Donnola, S; Eswarappa, SM; Fan, Y; Fox, PL; Gong, Y; Hambardzumyan, D; Lathia, JD; Potdar, AA; Rich, JN1
Kjaer, A; Kristoffersen, K; Lassen, U; Madsen, J; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT1
Förster, S; Gempt, J; Hüttinger, S; Nekolla, S; Pyka, T; Ringel, F; Schwaiger, M; van Marwick, S; Wester, HJ1
Bilger, A; Bittner, MI; Firat, E; Grosu, AL; Meyer, PT; Milanović, D; Niedermann, G; Weber, WA; Wiedenmann, N1
Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S1
Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C1
Driever, PH; Grosse, F; Guggemos, A; Koch, A; Misch, M; Plotkin, M; Steffen, IG; Thomale, UW1
Blau, T; Dorn, F; Drzezga, A; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Hau, P; Herrlinger, U; Hutterer, M; Kebir, S; Kocher, M; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Schmidt, M; Stoffels, G1
Andersen, SB; Bøgeskov, L; Cleff, C; Coenen, HH; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Langen, KJ; Law, I; Nysom, K; Reifenberger, G; Sarikaya-Seiwert, S; Shah, NJ; Steiger, HJ; Stoffels, G1
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Lundemann, MJ; Munck Af Rosenschold, P; Ohlhues, L1
Eigenbrod, S; Jansen, NL; Janssen, H; Kreth, FW; Kretzschmar, H; la Fougere, C; Linn, J; Pöpperl, G; Simon, M; Suchorska, B; Tonn, JC; Weller, M1
Broholm, H; El Ali, H; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT; Urup, T1
Bette, S; Buchmann, N; Förster, S; Gempt, J; Meyer, B; Peschke, P; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ1
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Judov, N; Langen, KJ; Lohmann, P; Rota Kops, E; Sabel, M; Shah, NJ; Stoffels, G; Tellmann, L; Weiss, C1
Blau, T; Ceccon, G; Dunkl, V; Filss, C; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffel, M; Stoffels, G; Tscherpel, C; Weinzierl, M1
de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G1
Bette, S; Förster, S; Gempt, J; Hiob, D; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Wester, HJ1
Bette, S; Buchmann, N; Förschler, A; Förster, S; Gempt, J; Meyer, B; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ1
Hansen, AE; Henriksen, OM; Larsen, VA; Larsson, HBW; Law, I; Muhic, A; Poulsen, HS1
Ewelt, C; Hasselblatt, M; Holling, M; Jaber, M; Niederstadt, T; Stummer, W; Weckesser, M; Wölfer, J; Zoubi, T1
Desiderio, DM; Guo, T; Li, J; Li, M; Li, X; Peng, F; Sang, S; Yang, H; Zhan, X1
Coenen, HH; Filss, C; Galldiks, N; Langen, KJ; Oliveira, D; Schöneck, M; Shah, NJ; Stegmayr, C; Willuweit, A1
Fimmers, R; Galldiks, N; Glas, M; Herrlinger, U; Kebir, S; Langen, KJ; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Simon, M; Stoffels, G; Stuplich, M; Tzaridis, T1
Bette, S; Delbridge, C; Foerster, S; Gempt, J; Huber, T; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Zimmer, C1
Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW1
Bauer, JS; Buchmann, N; Delbridge, C; Gempt, J; Kläsner, B; Krause, BJ; Meyer, B; Pyka, T; Ringel, F1
Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT1
Alyami, W; Bouhlel, A; Li, A; McConathy, J; Rich, K; Yuan, L1
Andratschke, N; Brown, M; Gulden-Sala, W; Roth, P; Stupp, R; Weller, M1
Albert, NL; Bartenstein, P; Fendler, WP; Schmid-Tannwald, C; Schüller, U; Schweisthal, F; Suchorska, B; Tonn, JC; Unterrainer, M; Wenter, V1
Dunet, V; Prior, JO1
Bai, H; Huang, X; Tang, H; Yang, L; Zhou, H1
Domínguez-Prieto, M; González-Sánchez, A; Herrero-González, S; Jaraíz-Rodríguez, M; Medina, JM; Tabernero, A1
Ackermann, U; Burvenich, IJ; Gan, HK; Gong, S; Guo, N; Kocovski, P; Lee, FT; Liu, Z; O'Keefe, GJ; Rigopoulos, A; Scott, AM; Tochon-Danguy, H1
Ebner, Y; Egger, B; Fritsch, B; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; McCoy, M; Menhart, K; Meyer, PT; Proescholdt, M; Riemenschneider, MJ; Roelcke, U; Schröder, M; Stockhammer, G; Trinka, E; Urbach, H; Wendl, C; Willuweit, A1
Bauer, E; Ceccon, G; Filss, CP; Fink, GR; Galldiks, N; Hamisch, C; Judov, N; Kocher, M; Kuchelmeister, K; Langen, KJ; Lohmann, P; Rapp, M; Ruge, MI; Sabel, M; Sellhaus, B; Shah, NJ; Stoffels, G1
Kameyama, M; Umeda-Kameyama, Y1
Af Rosenschöld, PM; Christensen, IJ; Grunnet, K; Jensen, ML; Larsen, VA; Law, I; Poulsen, HS; Poulsen, SH; Urup, T1
Bundschuh, RA; Galldiks, N; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Landsberg, J; Langen, KJ; Rauschenbach, L; Scheffler, B; Schlaak, M1
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Moller, S; Munck Af Rosenschold, P; Poulsen, HS1
Cai, H; Guastella, AR; Juhász, C; Klinger, NV; Mangner, TJ; Michelhaugh, SK; Mittal, S; Muzik, O; Polin, LA; Xin, Y; Zhang, S1
Albert, NL; Bartenstein, P; Brendel, M; Kreth, FW; Muacevic, A; Nachbichler, SB; Romagna, A; Schmid-Tannwald, C; Tonn, JC; Unterrainer, M1
Ceccon, G; Filss, CP; Galldiks, N; Kamp, MA; Langen, KJ; Lohmann, P; Neumaier, B; Rapp, M; Sabel, M; Shah, NJ; Stegmayr, C; Stoffels, G1
Förster, S; Gempt, J; Göttler, J; Kaczmarz, S; Kluge, A; Lukas, M; Meyer, B; Mustafa, M; Preibisch, C; Pyka, T; Ringel, F; Schwaiger, M; Zimmer, C1
Chatelut, E; Concordet, D; de Mey, J; de Ridder, M; Duerinck, J; Everaert, H; Gandia, P; Heemskerk, J; Jaudet, C; Neyns, B; Vanbinst, AM1
Bundschuh, RA; Essler, M; Fimmers, R; Gaertner, FC; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Khurshid, Z; Scheffler, B1
Chan, M; Hsiao, E1
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Niyazi, M; Unterrainer, M1
Costa, JC; Engelholm, SA; Law, I; Lundemann, M; Muhic, A; Munck Af Rosenschold, P; Poulsen, HS1
Arbizu, J; Galldiks, N; Langen, KJ; Law, I; Pope, WB1
Abbassi, RH; Day, BW; Font, JS; Hoque, M; Johns, TG; Kassiou, M; Munoz, L; Phoa, AF; Reekie, TA; Ryan, RM; Stringer, BW; Zhou, Q1
Fischman, AJ1
Bogner, L; Eilles, C; Koelbl, O; Rickhey, M1
Buchegger, F; Casanova, N; Dipasquale, G; Haller, G; Miralbell, R; Nouet, P; Ratib, O; Rouzaud, M; Vees, H; Weber, DC; Zaidi, H; Zilli, T1
Bärtschi, E; Bruehlmeier, M; Buettner, UW; Hefti, M; Hofer, S; Roelcke, U; Uhlmann, C; Wyss, M1
Buchfelder, M; Doelken, M; Ganslandt, O; Kuwert, T; Linke, R; Nimsky, C; Pölking, E; Prante, O; Stadlbauer, A1
Fonyuy, N; Horn, P; Koch, A; Misch, M; Plotkin, M; Stockhammer, F1
Bachofner, A; Coenen, HH; Floeth, FW; Hamacher, K; Herzog, H; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Stoffels, G; Tellmann, L1
Attieh, C; Demirel, C; Eble, MJ; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G1
Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE1
Benouaich-Amiel, A; Bousquet, P; Cances-Lauwers, V; Clanet, M; Delisle, MB; Esquerré, JP; Gantet, P; Julian, A; Lubrano, V; Payoux, P; Roux, F; Sabatier, J; Sol, JC; Tafani, M; Tremoulet, M; Uro-coste, E1
Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN1
Aigner, RM; Dunzinger, A; Nussbaumer, K; Pichler, J; Pichler, R; Topakian, R; Weis, S; Wurm, G1
Blechschmidt, C; Czabanka, M; Koch, A; Misch, M; Plotkin, M; Stockhammer, F; Tuettenberg, J; Vajkoczy, P1
Birner, P; Guentchev, M; Natchev, S; Toumangelova-Uzeir, K1
Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F1
Bogner, L; Eilles, C; Koelbl, O; Morávek, Z; Rickhey, M1
Coenen, HH; Eble, MJ; Holy, R; Kaiser, HJ; Klotz, J; Langen, KJ; Nussen, S; Pinkawa, M; Piroth, MD; Stoffels, G1
Buchfelder, M; Doerfler, A; Fritscher, T; Graf, W; Hammen, T; Kasper, BS; Kasper, EM; Kerling, F; Kuwert, T; Linke, R; Lorber, B; Pauli, E; Prante, O; Schwab, S; Stefan, H; Struffert, T; Weigel, D1
Houlden, H; Paisán-Ruiz, C1
Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Egensperger, R; Eigenbrod, S; Geisler, J; Hartmann, C; Herms, J; Kreth, FW; Kreth, S; Kretzschmar, HA; Kunz, M; la Fougere, C; Linn, J; Lutz, J; Pöpperl, G; Thon, N; Tonn, JC; von Deimling, A1
Bartenstein, P; Belka, C; Ganswindt, U; Garny, S; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Siefert, A; Suchorska, B; Tonn, JC1
Altieri, S; Bortolussi, S; Burchielli, S; Del Guerra, A; Del Turco, S; Matteucci, M; Menichetti, L; Panetta, D; Pascali, G; Petroni, D; Salvadori, PA1
Coenen, HH; Eble, MJ; Galldiks, N; Herzog, H; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G1
Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Astner, ST; Grosu, AL; Heinemann, F; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA; Wester, HJ; Wiedenmann, N1
Hussaini, IM; Lopes, MB; Merk, BC; Owens, JL; Silva, CM1
Gotwald, T; Hutterer, M; Jacobs, AH; Kostron, H; Muigg, A; Nowosielski, M; Putzer, D; Staffen, W; Stockhammer, G; Tinkhauser, G; Trinka, E; Virgolini, IJ; Waitz, D1
Buchfelder, M; Dörfler, A; Ganslandt, O; Grummich, P; Hammen, T; Kuwert, T; Nimsky, C; Stadlbauer, A1
Anile, C; Baum, RP; Calcagni, ML; Galli, G; Giordano, A; Niesen, A; Taralli, S1
Bruehlmeier, M; Hefti, M; Hundsberger, T; Nitzsche, EU; Roelcke, U1
Buck, A; Dunet, V; Prior, JO; Rossier, C; Stupp, R1
Heinzel, A; Langen, KJ; Müller, D; Stock, S1
Jeong, SY; Lim, SM1
Angelidis, G; Georgoulias, P; Leondi, A; Psimadas, D; Valotassiou, V1
Coenen, HH; Eble, MJ; Filss, CP; Fink, GR; Galldiks, N; Holy, R; Kaiser, HJ; Langen, KJ; Nolte, KW; Pinkawa, M; Piroth, MD; Stoffels, G1
Bartenstein, P; Belka, C; Eigenbrod, S; Ganswindt, U; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Suchorska, B; Tonn, JC1
Coenen, HH; Filss, CP; Fink, GR; Galldiks, N; Herzog, H; Langen, KJ; Piroth, MD; Ruge, MI; Sabel, M; Shah, NJ; Stoffels, G1
Bachoo, RM; Cavenee, WK; Dang, J; DePinho, RA; Fenton, TR; Furnari, FB; Inda, MM; Iwanami, A; James, CD; Kuga, D; Marie, SK; Mischel, PS; Nathanson, D; Oba-Shinjo, SM; Ponte de Albuquerque, C; Tanaka, K; Uno, M; Vandenberg, SR; Wykosky, J; Yang, H; Zhou, H1
Coenen, HH; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffels, G1
Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB1
Beez, T; Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Galldiks, N; Heinzel, A; Langen, KJ; Rapp, M; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G1
Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ1
Felsberg, J; Floeth, FW; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Steiger, HJ1
Cattaneo, MG; Francolini, M; Massari, S; Perego, C; Pietrini, G; Pola, S; Raimondi, A; Vanoni, C; Vicentini, LM1
Archer, GE; Bigner, DD; Chewning, TA; Friedman, AH; Friedman, HS; Heimberger, AB; Learn, CA; McLendon, RE; Pracyk, JB; Sampson, JH; Tuck, FL1
Coenen, HH; Floeth, F; Hamacher, K; Herzog, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L1
Bröer, S; Coenen, HH; Hamacher, K; Jansen, P; Jarosch, M; Langen, KJ; Mühlensiepen, H; Zilles, K1
Cheng, X; Dang, YH; Wang, SZ; Zhou, Q1
SHAMIRZAEV, AIu1
Coenen, HH; Floeth, F; Hamacher, K; Hautzel, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L1
Egorin, MJ; Ilaria, RL; Minna, JD; Randle, DE; Wolff, NC1
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC1
Diestel, S; Laurini, C; Schmitz, B; Traub, O1
Aguzzi, A; Buck, A; Hermann, DM; Kaser-Hotz, B; Lutz, A; Pahnke, J; Radovanovic, I; Scheidegger, S; Spaeth, N; Verwey, J; Weber, B; Weishaupt, D; Westera, G; Wild, D; Wyss, MT1
Coenen, HH; Hamacher, K; Kloska, S; Kurlemann, G; Langen, KJ; Rickert, CH; Schober, O; Straeter, R; Wassmann, H; Weckesser, M1
Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Müller, HW; Pauleit, D; Reifenberger, G; Riemenschneider, MJ; Zilles, K1
Coenen, H; Floeth, FW; Hamacher, K; Langen, KJ; Messing-Jünger, M; Müller, HW; Pauleit, D; Reifenberger, G; Sabel, M; Steiger, HJ; Stummer, W; Weber, F; Wittsack, HJ; Woebker, G; Zilles, K1
Harada, N; Ishii, K; Ishiwata, K; Iwata, R; Kawamura, K; Kimura, Y; Kubota, K; Nariai, T; Oda, K; Tsukada, H1
Gildehaus, FJ; Goldbrunner, R; Holtmannspötter, M; Kreth, FW; Pöpperl, G; Tanner, P; Tatsch, K; Tonn, JC1
Chang, CW; Chen, JC; Hwang, JJ; Hwang, LC; Lee, TW; Liu, RS; Wang, HE; Wu, SY1
Bauer, D; Coenen, HH; Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Stoffels, G; Zilles, K1
Amoresano, A; Cioffi, FA; Columbano, L; d'Ischia, M; Di Cosmo, A; Di Cristo, C; Fiore, G; Monti, G; Palumbo, A; Pucci, P1
Chan, CH; Chan, SY; Lee, RH; Wong, WL1
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Tatsch, K; Tonn, JC1
Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT1
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Schnell, O; Tatsch, K; Tonn, JC1
Bauer, D; Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Pauleit, D; Stoffels, G; Weckesser, M1
Amthauer, H; Denecke, T; Felix, R; Feussner, A; Gneveckow, U; Gutberlet, M; Jordan, A; Meier-Hauff, K; Plotkin, M; Wust, P1
An, GI; Cheon, GJ; Chi, DY; Choi, CW; Chun, KS; Lee, KC; Lee, TS; Lim, SM; Moon, BS1
Bigner, DD; Friedman, HS; Hjelmeland, AB; Jackson, D; Keir, ST; Ohmori, O; Rich, JN; Shi, Q; Song, L; Wickman, S1
Bauer, R; Brust, P; Fischer, S; Ganapathy, V; Herzau, M; Hinz, R; Huggel, K; Makrides, V; Opfermann, T; Verrey, F; Weber, W; Wester, HJ1
Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT1
Bärtschi, E; Hefti, M; Hofer, S; Roelcke, U; Treyer, V; Uhlmann, C; Wyss, MT1
Britt, WJ; Cobbs, CS; Denham, S; Kraus, MH; Pieper, R; Soroceanu, L; Zhang, W1
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Seelos, K; Tatsch, K; Tonn, JC1
Herms, J; Kreth, FW; Mehrkens, JH; Pöpperl, G; Rachinger, W; Seelos, K; Tatsch, K; Tonn, JC1
Coenen, HH; Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Stoffels, G1
Bosch, DA; Habraken, JB; Hulshof, MC; Koot, RW; Paans, AM; Pruim, J1
Amthauer, H; Plotkin, M; Stockhammer, F; van Landeghem, FK; Woiciechowsky, C1
Becker, DP; Gadisseux, P; Ward, JD; Young, HF1
Franssen, EJ; Go, KG; Heesters, MA; Molenaar, WM; Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Visser, GM; Willemsen, AT1
Chang, KJ; Chung, NN; Lee, PH; Nguyen, TM; Schiller, PW1
Chen, JK; Cheng, HP; Hung, LM; Tsai, CH1
Go, KG; Luurtsema, G; Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Willemsen, AT1
Go, KG; Kamman, RL; Keuter, EJ; Metzemaekers, JD; Paans, AM; Pruim, J; Staal, MJ; Vaalburg, W1
de Wolde, H; Koudstaal, J; Mastik, MF; Molenaar, WM; Pruim, J1
Blomquist, E; Bolander, H; Carlsson, J; Gedda, L; Hartvig, P; Janson, J; Lundqvist, H; Mellstedt, H; Nilsson, S; Nistèr, M; Sundin, A; Tolmachev, V; Westlin, J; Zhao, Q1
Heiss, P; Herz, M; Schwaiger, M; Senekowitsch-Schmidtke, R; Stöcklin, G; Weber, W; Wester, HJ1
Chen, F; Coy, DH; Diaco, DS; Drouant, GJ; Espenan, GD; Fisher, DR; Fuselier, JA; Maloney, TM; Murphy, WA; Nelson, JA; O'Dorisio, MS; O'Dorisio, TM; Sharma, C; Woltering, EA1
Kolchinsky, A1
Menter, DG; Schaefer, LK; Schaefer, TS1
Dzewas, B; Feldmann, HJ; Grosu, AL; Herz, M; Molls, M; Schwaiger, M; Stöcklin, G; Weber, WA; Wester, HJ1
Kreutzfeld, R; Preuss, U; Scheidtmann, KH1
Ali-Osman, F; Mullapudi, SR; Shou, J; Srivenugopal, KS1
Arun, P; Deepadevi, KV; Kurup, PA; Manojkumar, V; Ravikumar, A1
Arun, P; Devi, KV; Kurup, PA; Ravikumar, A1
de Vries, EG; Jager, PL; Langen, KJ; Piers, DA; Pruim, J; Vaalburg, W1
Bedecs, K; Lindegren, H; Ostlund, P; Pettersson, C1
Szydlowska, H1
Andersson, A; Capala, J; Carlsson, J1
Coenen, HH; Heiss, WD; Herholz, K; Kling, P; Rudolf, J; Stöcklin, G; Wienhard, K1
Bakker, WH; Krenning, EP; Lamberts, SW; Reubi, JC1
Chen, QZ; Dong, YJ; Liu, BH; Shao, KS; Wang, YH; Xu, FH; Xu, HJ; Xu, JJ; Xu, JP; Zhu, SL1
Abdullakhozhaeva, MS; Dimant, IN; Faĭn, NG1
Anton, AH; Greer, M; Williams, CM1

Reviews

20 review(s) available for tyrosine and Benign Neoplasms, Brain

ArticleYear
Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:5

    Topics: Amino Acids; Brain Neoplasms; Diagnosis, Differential; Humans; Methionine; Positron-Emission Tomography; Sensitivity and Specificity; Tyrosine

2023
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
    Journal of neuro-oncology, 2023, Volume: 161, Issue:1

    Topics: Brain Neoplasms; Contrast Media; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2023
Current trends in the use of O-(2-[
    Nuclear medicine and biology, 2021, Volume: 92

    Topics: Animals; Brain Neoplasms; Humans; Tyrosine

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
    Methods (San Diego, Calif.), 2017, 11-01, Volume: 130

    Topics: Animals; Brain Neoplasms; Humans; Positron-Emission Tomography; Protein Transport; Tyrosine

2017
Methods for molecular imaging of brain tumours in a hybrid MR-PET context: Water content, T
    Methods (San Diego, Calif.), 2017, 11-01, Volume: 130

    Topics: Animals; Brain Neoplasms; Diffusion; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Tyrosine; Water

2017
Recent Developments of 18F-FET PET in Neuro-oncology.
    Current medicinal chemistry, 2018, Volume: 25, Issue:26

    Topics: Brain Neoplasms; Humans; Positron-Emission Tomography; Tyrosine

2018
Accuracy of
    World neurosurgery, 2018, Volume: 114

    Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine

2018
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
    Acta neurochirurgica, 2018, Volume: 160, Issue:7

    Topics: Brain Neoplasms; Carbon Radioisotopes; Glioma; Humans; Methionine; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Tyrosine

2018
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
    Current radiopharmaceuticals, 2019, Volume: 12, Issue:3

    Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Fluorine Radioisotopes; Humans; Medical Oncology; Microvessels; Radiopharmaceuticals; Tyrosine

2019
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
    Current radiopharmaceuticals, 2019, Volume: 12, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine

2019
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:11

    Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Neoplasm Grading; Positron-Emission Tomography; Tyrosine

2019
[Gliomas – What I Have to Know in ten Questions].
    Praxis, 2016, Mar-16, Volume: 105, Issue:6

    Topics: Anticoagulants; Anticonvulsants; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Glioblastoma; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Oligodendroglioma; Positron-Emission Tomography; Tyrosine

2016
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
    NeuroImage. Clinical, 2017, Volume: 13

    Topics: Amino Acids; Brain Neoplasms; Dihydroxyphenylalanine; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2017
PET imaging of brain tumors.
    Cancer treatment and research, 2008, Volume: 143

    Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2008
Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:2

    Topics: Animals; Brain Neoplasms; Diagnosis, Differential; Glioma; Humans; Positron-Emission Tomography; Quality Control; Tyrosine

2012
Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.
    Neurosurgical focus, 2013, Volume: 34, Issue:2

    Topics: Animals; Brain Neoplasms; Glioma; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2013
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
    Nuclear medicine and biology, 2006, Volume: 33, Issue:3

    Topics: Animals; Biological Transport; Brain Neoplasms; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Tyrosine

2006
Nutrition and the neurosurgical patient.
    Journal of neurosurgery, 1984, Volume: 60, Issue:2

    Topics: Acetylcholine; Brain; Brain Injuries; Brain Neoplasms; Catecholamines; Choline; Endocrine Glands; Energy Metabolism; Humans; Nitrogen; Nutritional Physiological Phenomena; Serotonin; Tryptophan; Tyrosine

1984
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:3

    Topics: Amino Acids; Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphoma; Methionine; Methyltyrosines; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tyrosine

2001

Trials

25 trial(s) available for tyrosine and Benign Neoplasms, Brain

ArticleYear
[
    BMJ open, 2023, 08-04, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Australia; Brain Neoplasms; Clinical Trials, Phase II as Topic; Ficus; Glioblastoma; Humans; Magnetic Resonance Imaging; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tyrosine

2023
Boosting the acceptance of
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:13

    Topics: Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
MRI and
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 01-01, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Bevacizumab; Brain; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Tyrosine

2021
Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
    AJR. American journal of roentgenology, 2018, Volume: 211, Issue:6

    Topics: Angiogenesis Inhibitors; Bevacizumab; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Tyrosine

2018
Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: Adolescent; Adult; Aged; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Temozolomide; Tumor Burden; Tyrosine

2019
Prognostic value of
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 121, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Radiation; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Re-Irradiation; Treatment Outcome; Tumor Burden; Tyrosine

2016
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
    Radiation oncology (London, England), 2008, Dec-24, Volume: 3

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tyrosine

2008
Early metabolic responses in temozolomide treated low-grade glioma patients.
    Journal of neuro-oncology, 2009, Volume: 95, Issue:1

    Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Fluorine Radioisotopes; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Temozolomide; Time Factors; Tyrosine; Young Adult

2009
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:7

    Topics: Adolescent; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tyrosine; Young Adult

2009
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
    Radiation oncology (London, England), 2009, Nov-23, Volume: 4

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tyrosine

2009
Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.
    Archives of neurology, 2010, Volume: 67, Issue:3

    Topics: Brain; Brain Neoplasms; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Positron-Emission Tomography; Prospective Studies; Tyrosine

2010
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:4

    Topics: Adult; Aged; Aminolevulinic Acid; Blood-Brain Barrier; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spectrometry, Fluorescence; Tyrosine

2011
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies; Tyrosine

2012
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tyrosine

2013
Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tyrosine

2004
Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:11

    Topics: Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine

2004
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2005
Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:3

    Topics: Adult; Animals; Brain Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Haplorhini; Humans; Inflammation; Male; Metabolic Clearance Rate; Oligodendroglioma; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Survival Analysis; Tissue Distribution; Turpentine; Tyrosine

2005
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:9

    Topics: Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine

2005
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:3

    Topics: Adult; Algorithms; Brain; Brain Neoplasms; Computer Simulation; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Tyrosine

2006
Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:7

    Topics: Adult; Brachytherapy; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine

2006
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2006, Volume: 22, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Nanostructures; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tyrosine

2006
Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs.
    The journal of peptide research : official journal of the American Peptide Society, 1999, Volume: 53, Issue:2

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenylyl Cyclase Inhibitors; Aged; Amino Acid Sequence; Brain Neoplasms; Diagnostic Imaging; Growth Hormone; Humans; Iodine; Lung Neoplasms; Male; Neuroblastoma; Peptides; Radionuclide Imaging; Somatostatin; Tissue Distribution; Tumor Cells, Cultured; Tyrosine

1999
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine

2000

Other Studies

239 other study(ies) available for tyrosine and Benign Neoplasms, Brain

ArticleYear
18F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study.
    Croatian medical journal, 2021, Aug-31, Volume: 62, Issue:4

    Topics: Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
18F-FET PET/CT as a Diagnostic Tool for Brain Abscess.
    Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10

    Topics: Brain Abscess; Brain Neoplasms; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
    Journal of medical imaging and radiation oncology, 2022, Volume: 66, Issue:3

    Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tyrosine; World Health Organization

2022
    Journal of neuro-oncology, 2021, Volume: 155, Issue:1

    Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tyrosine; World Health Organization

2021
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement.
    Scientific reports, 2021, 10-21, Volume: 11, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine; Young Adult

2021
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.
    Cancer letters, 2022, 05-01, Volume: 533

    Topics: Apoptosis; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Glioblastoma; Humans; Phosphorylation; STAT3 Transcription Factor; Tyrosine

2022
Clinical Usefulness of 18 F-FET PET in a Pediatric Patient With Suspected Demyelinating Disease.
    Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8

    Topics: Brain Neoplasms; Child; Demyelinating Diseases; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tyrosine

2022
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma.
    Neuro-oncology, 2022, 10-03, Volume: 24, Issue:10

    Topics: Brain Neoplasms; Child; Glioma; Histones; Humans; Mutation; RNA, Small Interfering; STAT3 Transcription Factor; Tyrosine

2022
Cost Effectiveness of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:11

    Topics: Brain Neoplasms; Cost-Benefit Analysis; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Temozolomide; Tyrosine

2022
Safety and Efficacy of Irradiation Boost Based on 18F-FET-PET in Patients with Newly Diagnosed Glioblastoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 07-15, Volume: 28, Issue:14

    Topics: Brain Neoplasms; Glioblastoma; Humans; Necrosis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Tyrosine

2022
The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.
    International journal of molecular sciences, 2022, Jun-17, Volume: 23, Issue:12

    Topics: Biomarkers; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tyrosine

2022
Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study.
    Tomography (Ann Arbor, Mich.), 2022, 08-16, Volume: 8, Issue:4

    Topics: Brain Neoplasms; Glioma; Humans; Multiparametric Magnetic Resonance Imaging; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Tyrosine

2022
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
    Neuro-oncology, 2023, 05-04, Volume: 25, Issue:5

    Topics: Adult; Brain Neoplasms; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2023
Combination of pre-treatment dynamic [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:2

    Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2023
TSPO PET signal using [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:3

    Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Receptors, GABA; Tyrosine

2023
[
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:6

    Topics: Adolescent; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Decision-Making; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult

2023
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.
    Neuro-oncology, 2023, 06-02, Volume: 25, Issue:6

    Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Tyrosine

2023
Amino Acid PET in Neurooncology.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:5

    Topics: Amino Acids; Biopsy; Brain Neoplasms; Glioblastoma; Humans; Positron-Emission Tomography; Tyrosine

2023
Development of an economical method to synthesize O-(2-[
    Journal of labelled compounds & radiopharmaceuticals, 2023, Volume: 66, Issue:11

    Topics: Biological Transport; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2023
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:10

    Topics: Amino Acids; Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2023
[The clinical impact of amino acid positron emission tomography measurements in the treatment of primary malignant brain tumors].
    Orvosi hetilap, 2023, Aug-13, Volume: 164, Issue:32

    Topics: Adult; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2023
Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:11

    Topics: Amino Acids; Brain Neoplasms; Female; Genotype; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Tyrosine

2023
Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells.
    Journal of natural products, 2019, 09-27, Volume: 82, Issue:9

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; DNA, Neoplasm; Drug Synergism; Glioblastoma; Humans; Phosphodiesterase Inhibitors; Temozolomide; Thiourea; Tyrosine; Urea

2019
PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
    Molecular cell, 2019, 11-07, Volume: 76, Issue:3

    Topics: Adenosine Triphosphate; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glioblastoma; Glucose; Glycolysis; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphoglycerate Kinase; Phosphorylation; Prognosis; PTEN Phosphohydrolase; Signal Transduction; Time Factors; Tumor Burden; Tyrosine

2019
Quantitative biparametric analysis of hybrid
    Scientific reports, 2019, 10-10, Volume: 9, Issue:1

    Topics: Adult; Area Under Curve; Brain Neoplasms; Central Nervous System Neoplasms; False Positive Reactions; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Treatment Outcome; Tyrosine

2019
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
    Neuro-oncology, 2019, 12-17, Volume: 21, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tyrosine; Young Adult

2019
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tyrosine

2020
18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2020
Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Amides; Amino Acids; Biology; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Perfusion; Positron-Emission Tomography; Protons; Tyrosine

2020
Flare Phenomenon in
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Preoperative Period; Tyrosine

2020
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Astrocytoma; Brain Neoplasms; Humans; Isocitrate Dehydrogenase; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2020
Targeting glioma-initiating cells via the tyrosine metabolic pathway.
    Journal of neurosurgery, 2020, Feb-14, Volume: 134, Issue:3

    Topics: Base Sequence; Brain Neoplasms; Cell Line, Tumor; Cells, Cultured; Chemotherapy, Adjuvant; Drug Delivery Systems; Glioma; Humans; Immunohistochemistry; Metabolic Networks and Pathways; Metabolomics; Nitrogen; Tyrosine; Tyrosine Transaminase

2020
Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.
    PloS one, 2020, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Biological Transport; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Values; Tyrosine; Young Adult

2020
Radiotherapy target volume definition in newly diagnosed high grade glioma using
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 150

    Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Perfusion; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine

2020
Flare Phenomenon in
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:12

    Topics: Brain Neoplasms; Glioma; Humans; Ischemia; Positron-Emission Tomography; Tyrosine

2020
Reply: Flare Phenomenon in
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:12

    Topics: Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Tyrosine

2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, Volume: 62, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Retrospective Studies; Treatment Outcome; Tyrosine

2021
Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:12

    Topics: Adult; Biological Transport; Biopsy; Brain Neoplasms; Carbazoles; Glioma; Histones; Humans; Male; Mutation; Positron-Emission Tomography; Tyrosine

2020
Sequential implementation of DSC-MR perfusion and dynamic [
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6

    Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Perfusion; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2021
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
    Journal of neuro-oncology, 2021, Volume: 152, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
Benefit of Static FET PET in Pretreated Pediatric Brain Tumor Patients with Equivocal Conventional MRI Results.
    Klinische Padiatrie, 2021, Volume: 233, Issue:3

    Topics: Brain Neoplasms; Child; Humans; Infant; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tyrosine

2021
A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs.
    IEEE transactions on medical imaging, 2021, Volume: 40, Issue:7

    Topics: Adult; Brain Neoplasms; Glioma; Humans; Kinetics; Positron-Emission Tomography; Tyrosine

2021
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult Glioblastoma.
    Clinical nuclear medicine, 2021, 06-01, Volume: 46, Issue:6

    Topics: Adult; Brain Neoplasms; Female; Glioblastoma; Humans; Lateral Ventricles; Positron Emission Tomography Computed Tomography; Recurrence; Tyrosine

2021
Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; CSK Tyrosine-Protein Kinase; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Glioblastoma; Humans; Neoplasm Invasiveness; Paxillin; Phosphorylation; Progesterone; Protein-Tyrosine Kinases; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Tyrosine

2021
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors.
    Neuro-oncology, 2021, 12-01, Volume: 23, Issue:12

    Topics: Adult; Brain Neoplasms; Child; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
Multimodal assessment of disease activity in glioblastoma : A single center experience.
    Wiener klinische Wochenschrift, 2021, Volume: 133, Issue:21-22

    Topics: Brain Neoplasms; Glioblastoma; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 07-01, Volume: 27, Issue:13

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Temozolomide; Tyrosine

2021
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.
    Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9

    Topics: Adult; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Young Adult

2021
Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    Journal of neurosurgery, 2022, Jan-01, Volume: 136, Issue:1

    Topics: Adult; Aminolevulinic Acid; Brain Neoplasms; Chromosome Deletion; Female; Fluorescence; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Photosensitizing Agents; Positron-Emission Tomography; Protoporphyrins; Radiopharmaceuticals; Spectrometry, Fluorescence; Tyrosine

2022
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
    Pituitary, 2021, Volume: 24, Issue:6

    Topics: Adenoma; Brain Neoplasms; Cohort Studies; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2021
Determination of an Optimal Pharmacokinetic Model of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:8

    Topics: Animals; Brain Neoplasms; Kinetics; Male; Models, Biological; Positron-Emission Tomography; Rats; Tissue Distribution; Tyrosine

2017
Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
    Journal of medical imaging and radiation oncology, 2018, Volume: 62, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Tyrosine

2018
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.
    Neuro-oncology, 2018, 01-22, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Child; Chromosomes, Human, Pair 19; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Time Factors; Tyrosine; Young Adult

2018
AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adaptor Proteins, Signal Transducing; Adult; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Gene Expression Regulation; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Positron-Emission Tomography; Toxoplasmosis, Cerebral; Tyrosine

2017
Evaluation of factors influencing
    NeuroImage. Clinical, 2018, Volume: 17

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sex Factors; Tyrosine; Young Adult

2018
Radiosynthesis and modified quality control of O-(2-[
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2018, Volume: 133

    Topics: Brain Neoplasms; Equipment Design; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Technology, Radiologic; Tyrosine

2018
Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Protons; Tyrosine; Young Adult

2018
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2018
The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Journal of neurosurgery, 2018, 04-06, Volume: 130, Issue:2

    Topics: Adult; Biomarkers, Tumor; Brain Neoplasms; Cell Transformation, Neoplastic; Female; Glioma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Oligodendroglia; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Tyrosine

2018
O-(2-(
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult

2019
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2018, Volume: 53

    Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2018
Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI.
    European journal of radiology, 2018, Volume: 103

    Topics: Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Vinyl Compounds

2018
Correlation of Dynamic O-(2-[
    World neurosurgery, 2018, Volume: 119

    Topics: Brain; Brain Neoplasms; Combined Modality Therapy; Fatal Outcome; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2018
[
    Theranostics, 2018, Volume: 8, Issue:14

    Topics: Administration, Intravenous; Animals; Brain Neoplasms; Disease Models, Animal; Glioma; Heterografts; Histocytochemistry; Luminescent Measurements; Neoplasm Transplantation; Rats; Surgery, Computer-Assisted; Treatment Outcome; Tyrosine

2018
Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis.
    NeuroImage. Clinical, 2018, Volume: 20

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Tyrosine; Vinyl Compounds; Young Adult

2018
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:11

    Topics: Brain Neoplasms; Central Nervous System Diseases; Diagnosis, Differential; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2018
Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 130

    Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Re-Irradiation; Tumor Burden; Tyrosine

2019
Can Early Postoperative O-(2-
    World neurosurgery, 2019, Volume: 121

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Electroencephalography; Evoked Potentials, Somatosensory; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography Scanners, X-Ray Computed; Tyrosine

2019
Feasibility and robustness of dynamic
    Scientific reports, 2018, 10-03, Volume: 8, Issue:1

    Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Carbon; Female; Glioma; Heavy Ion Radiotherapy; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Temozolomide; Tyrosine

2018
Role of
    World neurosurgery, 2019, Volume: 121

    Topics: Brain Neoplasms; Disease Management; Female; Follow-Up Studies; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2019
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden; Tyrosine

2019
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:12

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Female; Glioma; Histones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2018
A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
    Molecules (Basel, Switzerland), 2018, Nov-08, Volume: 23, Issue:11

    Topics: Animals; Brachytherapy; Brain Neoplasms; Cell Proliferation; Cell Survival; Disintegrins; Drug Synergism; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Recombinant Proteins; Snake Venoms; Temozolomide; Tyrosine; Xenograft Model Antitumor Assays

2018
Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 130

    Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden; Tyrosine

2019
Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[
    Clinical lung cancer, 2019, Volume: 20, Issue:2

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography; Tyrosine

2019
In Reply to Letter to the Editor Regarding "Can Early Postoperative O-(2-
    World neurosurgery, 2019, Volume: 123

    Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
    Cancer cell, 2019, 03-18, Volume: 35, Issue:3

    Topics: Animals; Brain Neoplasms; Cell Nucleus; DNA Repair; Female; Glioma; Humans; Male; Mice; Phosphorylation; PTEN Phosphohydrolase; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine; Xenograft Model Antitumor Assays

2019
Letter to the Editor Regarding "Can Early Postoperative O-(2-
    World neurosurgery, 2019, Volume: 123

    Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2019
Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.
    IEEE transactions on medical imaging, 2019, Volume: 38, Issue:8

    Topics: Bayes Theorem; Brain; Brain Neoplasms; Glioblastoma; Humans; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Radiotherapy Planning, Computer-Assisted; Tyrosine

2019
Prognostic Value of O-(2-[
    Molecular imaging and biology, 2019, Volume: 21, Issue:6

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Tyrosine; World Health Organization

2019
Comparison of [
    Molecular imaging and biology, 2020, Volume: 22, Issue:1

    Topics: Adult; Brain Neoplasms; Cohort Studies; Female; Fluorine Radioisotopes; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Tyrosine

2020
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
    Neuro-oncology, 2019, 10-09, Volume: 21, Issue:10

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Tyrosine; Young Adult

2019
Quantitative parametric maps of O-(2-[
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020, Volume: 40, Issue:4

    Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Young Adult

2020
Technical feasibility of [
    Radiation oncology (London, England), 2019, May-30, Volume: 14, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Female; Glioblastoma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Rats, Inbred F344; Treatment Outcome; Tumor Burden; Tyrosine

2019
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
    Neurosurgery, 2019, 12-01, Volume: 85, Issue:6

    Topics: Aminolevulinic Acid; Brain Neoplasms; Gadolinium; Glioblastoma; Humans; Optical Imaging; Positron-Emission Tomography; Tyrosine

2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Tyrosine; Young Adult

2019
Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?
    Neuro-oncology, 2019, 10-09, Volume: 21, Issue:10

    Topics: Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Tyrosine

2019
Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:10

    Topics: Aged; Astrocytoma; Brain Neoplasms; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Tyrosine

2019
Being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:5

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine

2013
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:7

    Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine

2013
Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
    Neuro-oncology, 2013, Volume: 15, Issue:7

    Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2013
Replay: being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:5

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine

2013
Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:6

    Topics: Animals; Biological Transport; Brain; Brain Neoplasms; Cell Line, Tumor; False Positive Reactions; Glioma; Gliosis; Male; Positron-Emission Tomography; Rats; Tyrosine

2013
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Monte Carlo Method; Neoplasm Grading; Positron-Emission Tomography; Recurrence; Treatment Outcome; Tyrosine

2013
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
    Neuro-oncology, 2013, Volume: 15, Issue:7

    Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2013
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2013, Volume: 109, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tyrosine; Young Adult

2013
Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.
    Biochimica et biophysica acta, 2013, Volume: 1832, Issue:12

    Topics: Albumins; Animals; Brain Neoplasms; Contrast Media; Cyclic N-Oxides; Disease Models, Animal; Free Radicals; Gadolinium DTPA; Glioma; Immunoglobulin G; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Oxidation-Reduction; Radiography; Spin Labels; Spin Trapping; Tumor Cells, Cultured; Tyrosine

2013
Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?
    Molecular imaging, 2013, Volume: 12, Issue:6

    Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine

2013
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:1

    Topics: Amidohydrolases; Animals; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dipeptidases; Humans; Hydrolysis; Positron-Emission Tomography; Prodrugs; Rats; Tyrosine

2014
Discriminating ability of (18)F-FET PET for several cerebral neoplastic lesions.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine

2014
Reply: discriminating ability of (18)F-FET PET for several cerebral neoplastic lesions.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine

2014
Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
    Nuclear medicine communications, 2014, Volume: 35, Issue:3

    Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Positron-Emission Tomography; Tyrosine

2014
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Time Factors; Tyrosine; Young Adult

2014
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
    Neuro-oncology, 2014, Volume: 16, Issue:3

    Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2014
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2

    Topics: Adult; Astrocytes; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk; Time Factors; Treatment Outcome; Tyrosine

2014
Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:4

    Topics: Adult; Aged; Amino Acids; Brain Neoplasms; Cerebellar Neoplasms; Cerebellum; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2014
Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression.
    International journal of molecular sciences, 2014, Mar-04, Volume: 15, Issue:3

    Topics: Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cnidium; Coumarins; Dose-Response Relationship, Drug; Down-Regulation; Focal Adhesion Protein-Tyrosine Kinases; Fruit; Glioblastoma; Humans; Matrix Metalloproteinase 13; Phosphorylation; Tyrosine

2014
Multimodal imaging in cerebral gliomas and its neuropathological correlation.
    European journal of radiology, 2014, Volume: 83, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult

2014
Combination of MRI and dynamic FET PET for initial glioma grading.
    Nuklearmedizin. Nuclear medicine, 2014, Aug-06, Volume: 53, Issue:4

    Topics: Adult; Brain Neoplasms; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2014
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
    Nature cell biology, 2014, Volume: 16, Issue:5

    Topics: Animals; Autocrine Communication; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasm Grading; Neovascularization, Pathologic; Phosphorylation; Profilins; RNA Interference; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment; Tyrosine; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein

2014
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Female; Glioblastoma; Heterografts; Humans; Irinotecan; Mice, Nude; Neuroimaging; Positron-Emission Tomography; Tyrosine

2014
Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.
    AJNR. American journal of neuroradiology, 2014, Volume: 35, Issue:10

    Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine

2014
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2014, Volume: 190, Issue:10

    Topics: Adult; Brain Neoplasms; Chloroquine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tyrosine

2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine

2014
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine

2015
(18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2015, Volume: 31, Issue:2

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Male; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine

2015
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Disease Progression; False Positive Reactions; Female; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2015
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tyrosine

2015
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
    Neuro-oncology, 2015, Volume: 17, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tyrosine; Young Adult

2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Neurology, 2015, Feb-17, Volume: 84, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Longitudinal Studies; Male; Microsurgery; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prospective Studies; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine

2015
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Magnetic Resonance Imaging; Membrane Proteins; Mice; Microvessels; Multimodal Imaging; Optical Imaging; Positron-Emission Tomography; RNA, Messenger; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2015
18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
    European journal of radiology, 2015, Volume: 84, Issue:5

    Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tyrosine

2015
Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
    European radiology, 2015, Volume: 25, Issue:10

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine

2015
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
    Neuro-oncology, 2015, Volume: 17, Issue:9

    Topics: Brain Neoplasms; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tyrosine

2015
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:9

    Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine

2015
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Tumor Burden; Tyrosine

2016
Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases.
    World neurosurgery, 2015, Volume: 84, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tumor Burden; Tyrosine

2015
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1

    Topics: Blood Volume; Brain Neoplasms; Feasibility Studies; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tumor Burden; Tyrosine

2016
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular
    Neurosurgery, 2016, Volume: 78, Issue:3

    Topics: Aged; Aminolevulinic Acid; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Female; Fluorescence; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2016
Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.
    Journal of the American Society for Mass Spectrometry, 2015, Volume: 26, Issue:12

    Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Astrocytoma; Blotting, Western; Brain; Brain Chemistry; Brain Neoplasms; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Proteins; Tandem Mass Spectrometry; Tyrosine

2015
Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:6

    Topics: Animals; Biological Transport; Brain Neoplasms; Dexamethasone; Disease Models, Animal; Glioma; Kinetics; Male; Positron-Emission Tomography; Rats; Reproducibility of Results; Tyrosine

2016
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 05-01, Volume: 22, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult

2016
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    World neurosurgery, 2016, Volume: 89

    Topics: Adult; Biomarkers, Tumor; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden; Tyrosine

2016
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine

2016
(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
    World neurosurgery, 2016, Volume: 89

    Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tyrosine

2016
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
    Nuclear medicine and biology, 2016, Volume: 43, Issue:3

    Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A

2016
Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Amino Acid Substitution; Amino Acids; Amino Acids, Neutral; Animals; Biological Transport; Brain; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Hydrogen; Male; Methylation; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine

2016
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tyrosine; Watchful Waiting; Young Adult

2016
Response to: Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
    Neuro-oncology, 2016, Volume: 18, Issue:7

    Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2016
Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
    Neuro-oncology, 2016, Volume: 18, Issue:7

    Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2016
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Animals; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Connexin 43; CSK Tyrosine-Protein Kinase; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplastic Stem Cells; Phosphorylation; Prosencephalon; Protein Domains; Proto-Oncogene Mas; Proto-Oncogene Proteins pp60(c-src); PTEN Phosphohydrolase; Rats; Rats, Wistar; src-Family Kinases; Tyrosine

2016
L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.
    Molecular imaging, 2016, Volume: 15

    Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Neoplasm Transplantation; Peptides; Radiopharmaceuticals; Tissue Distribution; Tyrosine

2016
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:1

    Topics: Adult; Aged; Amino Acid Transport Systems; Amino Acids; Biological Transport, Active; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Epilepsy; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2017
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
    Neuro-oncology, 2017, 02-01, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Tyrosine; Young Adult

2017
Strategy based on kinetics of O-(2-[
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:12

    Topics: Brain Neoplasms; Computer Simulation; Glioma; Humans; Image Enhancement; Models, Biological; Neoplasm Grading; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2016
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine

2017
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.
    Neuro-oncology, 2016, Volume: 18, Issue:10

    Topics: Brain Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2016
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:2

    Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, SCID; Molecular Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tryptophan; Tyrosine

2017
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [
    Radiation oncology (London, England), 2016, Oct-21, Volume: 11, Issue:1

    Topics: Brachytherapy; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; ROC Curve; Tyrosine

2016
Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase
    European radiology, 2017, Volume: 27, Issue:7

    Topics: Adolescent; Aged; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiometry; Tyrosine; Young Adult

2017
Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cerebral Angiography; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2017
Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
    Clinical pharmacokinetics, 2017, Volume: 56, Issue:8

    Topics: Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2017
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
    Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Cluster Analysis; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; Tyrosine; Unsupervised Machine Learning

2017
Neurosarcoidosis on FET and FDG PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2017
    Journal of neuro-oncology, 2017, Volume: 132, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Female; Glioma; Humans; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Nonlinear Dynamics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Survival Analysis; Time Factors; Tyrosine; Young Adult

2017
Patterns of failure for patients with glioblastoma following O-(2-[
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017, Volume: 122, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Failure; Tyrosine

2017
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.
    Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5

    Topics: Brain Neoplasms; Glioblastoma; Humans; Phosphorylation; Protein Kinases; Structure-Activity Relationship; Tyrosine

2017
A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2008, Volume: 184, Issue:10

    Topics: Aged; Brain Neoplasms; Feasibility Studies; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Monte Carlo Method; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine

2008
Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
    Acta neurochirurgica, 2009, Volume: 151, Issue:9

    Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Male; Middle Aged; Movement Disorders; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Pyramidal Tracts; Radiography; Sensation Disorders; Sensitivity and Specificity; Tyrosine

2009
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
    Acta neurochirurgica, 2009, Volume: 151, Issue:11

    Topics: Adult; Aged; Aminolevulinic Acid; Biomarkers, Tumor; Brain Neoplasms; Female; Fluorescence; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neuronavigation; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Tyrosine

2009
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:1

    Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult

2010
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
    Bulletin du cancer, 2010, Volume: 97, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine

2010
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Tyrosine

2010
Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.
    Journal of neuro-oncology, 2010, Volume: 100, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclooxygenase 2 Inhibitors; Dacarbazine; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Fluorine Radioisotopes; Follow-Up Studies; Glioblastoma; Humans; Male; Methylation; Middle Aged; Positron-Emission Tomography; Pyrazoles; Retrospective Studies; Sulfonamides; Temozolomide; Tumor Suppressor Proteins; Tyrosine

2010
STAT3 tyrosine phosphorylation influences survival in glioblastoma.
    Journal of neuro-oncology, 2010, Volume: 100, Issue:3

    Topics: Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phosphorylation; Retrospective Studies; Signal Transduction; STAT3 Transcription Factor; Statistics, Nonparametric; Tyrosine

2010
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
    European radiology, 2010, Volume: 20, Issue:10

    Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine

2010
18F-FET-PET-based dose painting by numbers with protons.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2010, Volume: 186, Issue:6

    Topics: Algorithms; Brain Neoplasms; Fluorine Radioisotopes; Glioblastoma; Humans; Linear Energy Transfer; Monte Carlo Method; Photons; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tyrosine

2010
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
    International journal of radiation oncology, biology, physics, 2011, May-01, Volume: 80, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Temozolomide; Tyrosine

2011
18Fluoroethyl-L-tyrosine-PET in long-term epilepsy associated glioneuronal tumors.
    Epilepsia, 2011, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Cohort Studies; Epilepsy; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Tyrosine; Young Adult

2011
Common pathogenic pathways in melanoma and Parkinson disease.
    Neurology, 2010, Nov-02, Volume: 75, Issue:18

    Topics: Brain Neoplasms; Group VI Phospholipases A2; Humans; Levodopa; Melanoma; Neural Pathways; Parkinson Disease; Tyrosine

2010
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.
    Neuro-oncology, 2011, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; DNA Methylation; Female; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Promoter Regions, Genetic; Prospective Studies; Radiopharmaceuticals; Tyrosine; World Health Organization; Young Adult

2011
FET-PET for malignant glioma treatment planning.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:1

    Topics: Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2011
A micro-PET/CT approach using O-(2-[18F]fluoroethyl)-L-tyrosine in an experimental animal model of F98 glioma for BNCT.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2011, Volume: 69, Issue:12

    Topics: Animals; Boron Neutron Capture Therapy; Brain Neoplasms; Disease Models, Animal; Glioma; Multimodal Imaging; Positron-Emission Tomography; Rats; Tomography, X-Ray Computed; Tyrosine

2011
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Fluorine Radioisotopes; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine

2011
Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:7

    Topics: Adult; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Carcinoma; Contrast Media; Female; Fluorescence; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Tyrosine

2011
An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    International journal of radiation oncology, biology, physics, 2011, Nov-15, Volume: 81, Issue:4

    Topics: Brain; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tumor Burden; Tyrosine

2011
STAT6 expression in glioblastoma promotes invasive growth.
    BMC cancer, 2011, May-20, Volume: 11

    Topics: Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Databases, Factual; Epidermal Growth Factor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Glioma; Humans; Neoplasm Invasiveness; Phosphorylation; RNA, Small Interfering; STAT6 Transcription Factor; Survival Analysis; Tyrosine

2011
O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6

    Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Combined Modality Therapy; Disease-Free Survival; Female; Glioma; Humans; Image Processing, Computer-Assisted; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Failure; Tyrosine; Ultrasonography

2011
Classification of peritumoral fiber tract alterations in gliomas using metabolic and structural neuroimaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Nervous System Diseases; Neurology; Neurons; Positron-Emission Tomography; Prognosis; Tyrosine

2011
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Time Factors; Tyrosine; Young Adult

2011
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:1

    Topics: Adult; Brain Neoplasms; Choline; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2012
Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:7

    Topics: Biopsy; Brain Neoplasms; Cost-Benefit Analysis; Decision Trees; Glioma; Humans; Magnetic Resonance Imaging; Monte Carlo Method; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2012
SPECT and PET imaging of meningiomas.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Acetic Acid; Adult; Ammonia; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Meningioma; Nitrogen Radioisotopes; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine

2012
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Contrast Media; Disease Progression; Disease-Free Survival; Female; Gadolinium; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tyrosine

2012
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 104, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tumor Suppressor Proteins; Tyrosine

2012
Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:9

    Topics: Adolescent; Adult; Aged; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; ROC Curve; Tyrosine; Young Adult

2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Aug-28, Volume: 109, Issue:35

    Topics: Animals; Astrocytes; Brain Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Mice; Mice, Mutant Strains; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Quinazolines; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine

2012
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
    Journal of neuro-oncology, 2012, Volume: 110, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult

2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Brain Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tyrosine

2013
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
    Neuro-oncology, 2013, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult

2013
Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system.
    Journal of cell science, 2002, Aug-15, Volume: 115, Issue:Pt 16

    Topics: Adaptor Proteins, Signal Transducing; Adherens Junctions; Animals; Astrocytes; beta Catenin; Brain Neoplasms; Cadherins; Cell Adhesion; Cell Movement; Cells, Cultured; Cytoskeletal Proteins; Glioblastoma; Humans; Membrane Proteins; Microscopy, Confocal; Microscopy, Electron, Scanning; Neoplasm Invasiveness; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Trans-Activators; Tumor Cells, Cultured; Tyrosine; Vesicular Transport Proteins

2002
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:11

    Topics: 3T3 Cells; Administration, Oral; Animals; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; DNA Mutational Analysis; Enzyme Inhibitors; ErbB Receptors; Flow Cytometry; Gefitinib; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; Time Factors; Tumor Cells, Cultured; Tyrosine

2002
Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:4

    Topics: Adult; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Whole-Body Counting

2003
Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.
    Nuclear medicine and biology, 2003, Volume: 30, Issue:5

    Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Cell Line, Tumor; Glioma; Male; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution; Tissue Transplantation; Tyrosine

2003
[Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2002, Volume: 24, Issue:4

    Topics: Adult; Animals; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Middle Aged; Sarcoma 180; Tomography, Emission-Computed; Tyrosine

2002
[ON THE DISTRIBUTION OF TYROSINE C-14 IN THE RAT BRAIN IN THE PRESENCE OF TRANSPLANTABLE BRAIN TUMORS AND ITS ACUTE PROLAPSE].
    Meditsinskii zhurnal Uzbekistana, 1964, Volume: 1

    Topics: Autoradiography; Brain; Brain Neoplasms; Carbon Isotopes; Metabolism; Neoplasm Transplantation; Neoplasms, Experimental; Prolapse; Radiometry; Rats; Research; Tyrosine

1964
Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, May-15, Volume: 10, Issue:10

    Topics: Animals; Antineoplastic Agents; Benzamides; Brain Neoplasms; Carcinoma, Small Cell; Cell Line, Tumor; Humans; Imatinib Mesylate; Immunoblotting; Immunoprecipitation; Ligands; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; NIH 3T3 Cells; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Signal Transduction; Stem Cell Factor; Time Factors; Tyrosine

2004
Tyrosine 734 of NCAM180 interferes with FGF receptor-dependent signaling implicated in neurite growth.
    Biochemical and biophysical research communications, 2004, Sep-10, Volume: 322, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Division; Cell Line; Chlorocebus aethiops; COS Cells; Humans; Neural Cell Adhesion Molecules; Neurites; Neuroblastoma; Rats; Receptors, Fibroblast Growth Factor; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship; Tyrosine

2004
Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:11

    Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine

2004
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
    Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 3

    Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tyrosine

2005
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Journal of neurosurgery, 2005, Volume: 102, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Energy Metabolism; Female; Fluorine Radioisotopes; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuronavigation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine

2005
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:4

    Topics: Animals; Boron Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glycopeptides; Metabolic Clearance Rate; Molecular Probe Techniques; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine

2005
Evaluation of new 18F-labeled amino acids for brain PET.
    Anatomy and embryology, 2005, Volume: 210, Issue:5-6

    Topics: Animals; Autoradiography; Brain; Brain Chemistry; Brain Diseases; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Proline; Rats; Tyrosine

2005
Tubulin nitration in human gliomas.
    Neuroscience letters, 2006, Feb-06, Volume: 394, Issue:1

    Topics: Aged; Astrocytes; Blotting, Western; Brain Neoplasms; Chromatography, High Pressure Liquid; Female; Glioma; Humans; Immunohistochemistry; Male; Middle Aged; Neurons; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tubulin; Tyrosine

2006
Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Journal of neuroscience research, 2006, Volume: 83, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; Immunoblotting; Ligands; Mitogen-Activated Protein Kinase 3; Neuroblastoma; Neurons; Neurturin; Phosphorylation; Proto-Oncogene Proteins c-ret; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tyrosine

2006
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:6

    Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine

2006
Syntheses of F-18 labeled fluoroalkyltyrosine derivatives and their biological evaluation in rat bearing 9L tumor.
    Bioorganic & medicinal chemistry letters, 2007, Jan-01, Volume: 17, Issue:1

    Topics: Animals; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Embedding; Tyrosine

2007
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Molecular carcinogenesis, 2007, Volume: 46, Issue:6

    Topics: Annexin A5; Antineoplastic Agents; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Neoplasm Invasiveness; Phosphorylation; Tyrosine

2007
Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Brain research, 2007, May-25, Volume: 1147

    Topics: Adult; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Stereoisomerism; Swine; Tissue Distribution; Tyrosine

2007
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:4

    Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovascularization, Pathologic; Radiopharmaceuticals; Rats; Rats, Wistar; Recombinant Fusion Proteins; Tyrosine

2007
Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:7

    Topics: Adult; Amino Acid Transport Systems; Brain Neoplasms; Capillaries; Cerebellum; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Microcirculation; Middle Aged; Oxygen Isotopes; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Water

2007
Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
    Journal of neuro-oncology, 2007, Volume: 85, Issue:3

    Topics: Astrocytes; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cell Movement; Cytomegalovirus; Cytomegalovirus Infections; ErbB Receptors; Fibroblasts; Focal Adhesion Kinase 1; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine

2007
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tyrosine

2007
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.
    Journal of neuro-oncology, 2008, Volume: 88, Issue:1

    Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Progression; Female; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stereotaxic Techniques; Tyrosine

2008
[Improved diagnostics of cerebral gliomas using FET PET].
    Zeitschrift fur medizinische Physik, 2007, Volume: 17, Issue:4

    Topics: Brain Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Germany; Glioma; Humans; Positron-Emission Tomography; Societies, Medical; Tyrosine

2007
What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Acta neurochirurgica, 2008, Volume: 150, Issue:4

    Topics: Adult; Aged; Brachytherapy; Brain; Brain Neoplasms; Carbon Radioisotopes; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Disease-Free Survival; Female; Follow-Up Studies; Glioblastoma; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine

2008
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas.
    Journal of neuro-oncology, 2008, Volume: 88, Issue:2

    Topics: Adult; Aged; Blood Vessels; Brain Neoplasms; Cell Count; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2008
Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate.
    Radiology, 1995, Volume: 197, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Glioma; Humans; Lymphoma, Non-Hodgkin; Male; Meningioma; Methionine; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Tomography, Emission-Computed; Tyrosine; Vasculitis

1995
Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist.
    European journal of pharmacology, 1995, Jul-04, Volume: 280, Issue:2

    Topics: Amino Acid Sequence; Analgesics; Animals; Brain Neoplasms; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Humans; Iodine; Mice; Molecular Sequence Data; Molecular Weight; Narcotic Antagonists; Neuroblastoma; Oligopeptides; Receptors, Opioid, delta; Spectrometry, Mass, Fast Atom Bombardment; Tetrahydroisoquinolines; Tumor Cells, Cultured; Tyrosine

1995
Increased intracellular cyclic AMP levels suppress the mitogenic responses of human astrocytoma cells to growth factors.
    Journal of neuro-oncology, 1995, Volume: 23, Issue:1

    Topics: Astrocytoma; Blotting, Western; Brain Neoplasms; Bucladesine; Cell Division; Cyclic AMP; Glial Fibrillary Acidic Protein; Growth Substances; Humans; Immunohistochemistry; Mitogens; Phosphorylation; Receptor Protein-Tyrosine Kinases; Thymidine; Tumor Cells, Cultured; Tyrosine

1995
In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:3

    Topics: Adult; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Models, Biological; Protein Biosynthesis; Recurrence; Tomography, Emission-Computed; Tyrosine

1995
Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy.
    Neurosurgery, 1994, Volume: 34, Issue:6

    Topics: Adult; Astrocytoma; Biopsy; Brain Neoplasms; Carbon Radioisotopes; Craniotomy; Female; Frontal Lobe; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stereotaxic Techniques; Temporal Lobe; Tomography, Emission-Computed; Tyrosine

1994
Proliferative activity in human brain tumors: comparison of histopathology and L-[1-(11)C]tyrosine PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Brain Neoplasms; Cell Division; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nucleolus Organizer Region; Silver Staining; Tomography, Emission-Computed; Tyrosine

1997
Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.
    International journal of molecular medicine, 1998, Volume: 1, Issue:4

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Dextrans; Epidermal Growth Factor; ErbB Receptors; Glioma; Iodine Radioisotopes; Mice; Tumor Cells, Cultured; Tyrosine

1998
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:1

    Topics: Animals; Astrocytoma; Brain Neoplasms; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Transplantation; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tyrosine

1999
First gene involved in glioblastoma progression identified.
    Surgical neurology, 1999, Volume: 52, Issue:1

    Topics: Brain Neoplasms; Cell Adhesion Molecules; Cell Division; Disease Progression; ErbB Receptors; Glioblastoma; Humans; Microfilament Proteins; Phosphorylation; Tensins; Tyrosine

1999
Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines.
    Cellular signalling, 2000, Volume: 12, Issue:3

    Topics: beta-Galactosidase; Brain Neoplasms; Chloramphenicol O-Acetyltransferase; Ciliary Neurotrophic Factor; Cytokines; DNA-Binding Proteins; DNA, Neoplasm; Fluorescent Antibody Technique, Indirect; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Oncostatin M; Peptides; Phosphorylation; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tyrosine

2000
Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation.
    International journal of cancer, 2000, Oct-15, Volume: 88, Issue:2

    Topics: Amino Acid Substitution; Animals; Antigens, Polyomavirus Transforming; Brain Neoplasms; Colony-Forming Units Assay; Cysteine; Genes, fos; Genes, p53; Genes, Reporter; Humans; Mutagenesis, Site-Directed; Osteosarcoma; Point Mutation; Promoter Regions, Genetic; Rats; Recombinant Proteins; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine

2000
DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.
    The Biochemical journal, 2000, Oct-15, Volume: 351 Pt 2

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Casein Kinase II; Cations; Chromatography, Agarose; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Genistein; Guanosine Triphosphate; Humans; Magnesium; Manganese; Medulloblastoma; Mice; Molecular Sequence Data; O(6)-Methylguanine-DNA Methyltransferase; Phosphates; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rats; Recombinant Proteins; Sequence Homology, Amino Acid; Serine; Threonine; Tumor Cells, Cultured; Tyrosine; Tyrphostins

2000
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
    Neurology India, 2000, Volume: 48, Issue:3

    Topics: Adult; Biogenic Monoamines; Brain Diseases; Brain Neoplasms; Digoxin; Epilepsy, Generalized; Erythrocytes; Fatty Acids, Nonesterified; Female; Glioma; Glycine Agents; Humans; Hydroxymethylglutaryl CoA Reductases; Kynurenic Acid; Magnesium; Male; Microvascular Angina; Middle Aged; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinolinic Acid; Schizophrenia; Serum Albumin; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine; Ubiquinone

2000
Endogenous strychnine, nicotine, and morphine--description of hypo and hyper-strychninergic, nicotinergic and morphinergic state in relation to neuropsychiatric diseases.
    Indian journal of experimental biology, 2000, Volume: 38, Issue:6

    Topics: Adult; Alkaloids; Brain Neoplasms; Chromatography, High Pressure Liquid; Erythrocyte Membrane; Glioma; Humans; Male; Mental Disorders; Middle Aged; Morphine; Neoplasm Proteins; Nervous System Diseases; Nicotine; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine

2000
Up-regulation of functionally impaired insulin-like growth factor-1 receptor in scrapie-infected neuroblastoma cells.
    The Journal of biological chemistry, 2001, Sep-28, Volume: 276, Issue:39

    Topics: Animals; Binding Sites; Brain Neoplasms; Cell Division; Coculture Techniques; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Neuroblastoma; Phosphorylation; Precipitin Tests; Protein Binding; Receptor, IGF Type 1; Reverse Transcriptase Polymerase Chain Reaction; Scrapie; Time Factors; Tumor Cells, Cultured; Tyrosine; Up-Regulation

2001
Histochemical investigations of thyrosine in normal and pathological glia cells.
    Folia histochemica et cytochemica, 1977, Volume: 15, Issue:3

    Topics: Astrocytes; Brain; Brain Neoplasms; Cell Nucleus; Cytoplasm; Humans; Neuroglia; Tyrosine

1977
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
    Journal of neuro-oncology, 1992, Volume: 14, Issue:3

    Topics: Brain Neoplasms; Cell Survival; Culture Media; Dextrans; Drug Carriers; Epidermal Growth Factor; Glioma; Humans; Iodine Radioisotopes; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrosine

1992
Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:7

    Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Deoxyglucose; Edetic Acid; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Tyrosine

1991
Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
    Zeitschrift fur Gastroenterologie, 1990, Volume: 28 Suppl 2

    Topics: Autoradiography; Brain Neoplasms; Breast Neoplasms; Humans; Iodine Radioisotopes; Multiple Endocrine Neoplasia; Octreotide; Pancreatic Neoplasms; Radiography; Radionuclide Imaging; Receptors, Neurotransmitter; Receptors, Somatostatin; Somatostatin; Tyrosine

1990
[The changes in noradrenaline content in CSF of patients under electroacupuncture].
    Zhen ci yan jiu = Acupuncture research, 1988, Volume: 13, Issue:3

    Topics: Acupuncture Therapy; Adolescent; Adult; Anesthesia; Brain Neoplasms; Electric Stimulation Therapy; Humans; Norepinephrine; Parkinson Disease; Serotonin; Transcutaneous Electric Nerve Stimulation; Tyrosine

1988
[Data towards the histochemical characteristics of brain tumors in rats].
    Arkhiv patologii, 1966, Volume: 28, Issue:5

    Topics: Animals; Arachnoid; Astrocytoma; Brain Neoplasms; DNA; Ependymoma; Glioblastoma; Glioma; Hemangioendothelioma; Histidine; Neoplasms, Experimental; Oligodendroglioma; Protein Biosynthesis; Rats; RNA; Tryptophan; Tyrosine

1966
Failure of enzyme inhibition therapy for malignant melanoma.
    Transactions of the American Neurological Association, 1969, Volume: 94

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Dopamine; Enzyme Repression; Epinephrine; Humans; Male; Melanoma; Neoplasm Metastasis; Norepinephrine; Tyrosine

1969